SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

01 Aug 2025 Evaluate
Net sales declined -7.61%  to  Rs. 358.73 million from Rs. 388.27 millions.The Net Profit of the company slipped to Rs. 90.62 millions from Rs. 132.37 millions, a decline of -31.54% on QoQ basis.Operating Profit reported a sharp decline to 141.96 millions from 190.75 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 358.73 388.27 -7.61 358.73 388.27 -7.61 1508.00 1698.22 -11.20
Other Income 2.74 5.24 -47.71 2.74 5.24 -47.71 24.32 43.66 -44.30
PBIDT 141.96 190.75 -25.58 141.96 190.75 -25.58 712.76 831.00 -14.23
Interest 0.42 0.66 -36.36 0.42 0.66 -36.36 3.64 2.29 58.95
PBDT 141.54 190.09 -25.54 141.54 190.09 -25.54 709.12 828.71 -14.43
Depreciation 20.34 11.48 77.18 20.34 11.48 77.18 53.75 35.36 52.01
PBT 121.20 178.61 -32.14 121.20 178.61 -32.14 655.37 793.35 -17.39
TAX 30.58 46.24 -33.87 30.58 46.24 -33.87 167.66 201.71 -16.88
Deferred Tax 5.92 0.53 1016.98 5.92 0.53 1016.98 2.80 3.75 -25.33
PAT 90.62 132.37 -31.54 90.62 132.37 -31.54 487.71 591.64 -17.57
Equity 108.97 72.64 50.01 108.97 72.64 50.01 108.97 72.64 50.01
PBIDTM(%) 39.57 49.13 -19.45 39.57 49.13 -19.45 47.27 48.93 -3.41

Guj. Themis Biosyn Share Price

319.45 15.45 (5.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×